~~<i id='183B288991'><strike id='183B288991'><tt id='183B288991'><pre id='183B288991'></pre></tt></strike></i>~~

Home» knowledge» explore

explore

author：comprehensive 2025-08-05 22:33:06 Page View：299

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： First over
Next article： Medicare proposal to cover medical devices draws a mixed reaction

knowledge

ChatGPT in medicine: STAT answers readers' burning questions

MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

More doctors should go into startup world

AdobeInmydecadelivinginSiliconValleyasadigitalhealthjournalistandnowaninvestor,Ican’ttellyouhowmanyt

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

For AI in health care standards, federal regulators join with industry group

AdobeAtfirstglance,theCoalitionforHealthAIlookslikeanytechnologylobbyinggroup.Itsmembership—includin